Clinical Trials
2 trialsNCT03152526 2020-07-09
CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploidentical Donor Natural Killer (NK) Cell Based Therapy for AML Patients Not in CR
Miltenyi Biomedicine GmbH
Phase NA Terminated
NCT03281746 2020-02-25
Effect of Prevention Education in Caries Formation in Pediatric Patients With Leukemia
Virginia Commonwealth University
Phase NA Terminated